Visusnano Limited
Research and experimental development on biotechnology · Canterbury
ActiveUnited KingdomIncorporated 2016Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2025-04-30
IXBRL · 138 source facts · 26 selected values
Validation findingsXBRL valid
Accounts to 2025-04-30
IXBRL · 138 source facts · 26 selected values
Validation findings
XBRL valid
- Reporting period
- 2024-05-01 to 2025-04-30
- Extraction status
- complete
- Numeric facts
- 78
- Documents processed
- 1
- XBRL standards validation
- valid
- Filing-profile validation
- invalid
- Parser
- arelle 2.44.4
- Taxonomy
- FRS-102-2024-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2601_10116150_20250430
- Source archive
- Accounts_Monthly_Data-January2026.zip
Extraction findings: filing rules invalid. These describe source processing, not an audit opinion on the company.
Accounts to 2024-04-30
IXBRL · 131 source facts · 26 selected values
Not assessedlegacy record
Accounts to 2024-04-30
IXBRL · 131 source facts · 26 selected values
Not assessed
legacy record
- Reporting period
- 2023-05-01 to 2024-04-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 72
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2023-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_2476_10116150_20240430
- Source archive
- Accounts_Monthly_Data-September2024.zip
Accounts to 2023-04-30
IXBRL · 131 source facts · 26 selected values
Not assessedlegacy record
Accounts to 2023-04-30
IXBRL · 131 source facts · 26 selected values
Not assessed
legacy record
- Reporting period
- 2022-05-01 to 2023-04-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 72
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0022_10116150_20230430
- Source archive
- Accounts_Monthly_Data-August2023.zip
Accounts to 2022-04-30
IXBRL · 136 source facts · 26 selected values
Not assessedlegacy record
Accounts to 2022-04-30
IXBRL · 136 source facts · 26 selected values
Not assessed
legacy record
- Reporting period
- 2021-05-01 to 2022-04-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 77
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0112_10116150_20220430
- Source archive
- Accounts_Monthly_Data-November2022.zip
Accounts to 2021-04-30
IXBRL · 137 source facts · 25 selected values
Not assessedlegacy record
Accounts to 2021-04-30
IXBRL · 137 source facts · 25 selected values
Not assessed
legacy record
- Reporting period
- 2020-05-01 to 2021-04-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 78
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2021-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0096_10116150_20210430
- Source archive
- Accounts_Monthly_Data-November2021.zip
Accounts to 2020-04-30
IXBRL · 129 source facts · 24 selected values
Not assessedlegacy record
Accounts to 2020-04-30
IXBRL · 129 source facts · 24 selected values
Not assessed
legacy record
- Reporting period
- 2019-05-01 to 2020-04-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 70
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0082_10116150_20200430
- Source archive
- Accounts_Monthly_Data-September2020.zip
Accounts to 2018-04-30
IXBRL · 65 source facts · 10 selected values
Not assessedlegacy record
Accounts to 2018-04-30
IXBRL · 65 source facts · 10 selected values
Not assessed
legacy record
- Reporting period
- 2017-05-01 to 2018-04-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 24
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0062_10116150_20180430
- Source archive
- Accounts_Monthly_Data-January2019.zip
Accounts to 2017-04-30
IXBRL · 64 source facts · 5 selected values
Not assessedlegacy record
Accounts to 2017-04-30
IXBRL · 64 source facts · 5 selected values
Not assessed
legacy record
- Reporting period
- 2016-05-01 to 2017-04-30
- Extraction status
- Legacy / not assessed
- Numeric facts
- 16
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2014-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0050_10116150_20170430
- Source archive
- Accounts_Monthly_Data-January2018.zip
Registered details
10116150- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2016-04-11
- Jurisdiction
- —
- Registered office
- CAMBURGH HOUSE, 27 NEW DOVER ROAD, CANTERBURY, KENT, CT1 3DN, UNITED KINGDOM
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
5 matched grantsExpanding MEDILens the drug eluting lens capabilitiesLeadLive
Innovate UK · Collaborative R&D · 2024-06-01 – 2026-10-31
£700,000
awarded
MEDILens, a Drug-eluting Intraocular LensLead
Innovate UK · Collaborative R&D · 2022-04-01 – 2025-03-31
£1,398,880
awarded
MEDILens - continuity support requestLead
Innovate UK · Feasibility Studies · 2020-06-01 – 2020-11-30
£58,479
awarded
Towards Dropless Cataract Surgery: MEDILens, a Drug-eluting Intraocular LensLead
Innovate UK · Study · 2020-05-01 – 2022-01-31
£225,404
awarded
Development of next-generation Intraocular lens combined with degradable drug delivery system toward prevention of Posterior Capsule OpacificationEPSRC · Research Grant · 2019-09-30 – 2023-08-30 · with 2 other participants£381,482whole project
Development of next-generation Intraocular lens combined with degradable drug delivery system toward prevention of Posterior Capsule Opacification
EPSRC · Research Grant · 2019-09-30 – 2023-08-30 · with 2 other participants
£381,482
whole project